As of 2026-04-04, the Relative Valuation of Infinity Pharmaceuticals Inc (INFI) is (29.05) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.04 USD, the upside of Infinity Pharmaceuticals Inc based on Relative Valuation is -65095.6%.
The range of the Relative Valuation is (27.63) - (29.12) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 21.9x - 24.3x | 24.2x |
| Forward P/E multiples | 21.2x - 23.1x | 21.9x |
| Fair Price | (27.63) - (29.12) | (29.05) |
| Upside | -61909.2% - -65236.6% | -65095.6% |
| Date | P/E |